Page 196 - Aet News Today

Read about news from Carrum Health, New Enterprise Associates, American Medical Women's Association, and Iaso Therapeutics.

Medtech companies should be particularly mindful of the following legal and regulatory compliance issues. This is especially true for companies transitioning to data-based services.

About 47% of American adults have hypertension and 14% have diabetes. Yet, 12% of people have set a goal to manage their blood pressure and 6% have a goal to manage their diabetes, a new HealthJoy survey found. Comparatively, about half of Americans have a musculoskeletal condition, and 35% of respondents are interested in managing back or joint pain.

This year’s ACA Marketplace enrollment represents a 13% increase, or 1.8 million people, from last year, according to CMS. There were more than 12.7 million returning consumers and more than 3.6 million new consumers.

Pearl Health — a technology company that helps independent physician practices participate in value-based care models — just raised $75 million in Series B financing. Pearl’s platform leverages data science to help primary care providers focus on patients who are driving expenses and need care the most.

Healthcare providers will continue having a difficult time retaining employees unless they make necessary changes, such as establishing pay increases and improving company culture. Healthcare ranked last for employee satisfaction with pay among 27 other industries, according to a recent report. A separate report found that many healthcare employees are leaving their jobs because their company’s mission no longer aligns with their values.

It’s no secret that healthcare in the United States has become unaffordable. In fact, a recent Gallup survey found nearly one in five U.S. adults—a whopping 46 million people—reported they would be unable to pay for high-quality healthcare if they needed it. Healthcare spending has steadily risen over the past several years, and what’s more, high healthcare costs tend to disproportionately impact individuals with the most complex care needs. For example, those living with chronic condit...

The agency’s goal is to spur a macro shift in clinical trials. The FDA is trying to tell these companies what it wants to be different in trials across the board with regards to digital health endpoints, the use of real-world data (RWD) as regulatory-grade data, and diversity in clinical trial inclusion.

After launching an at-home vaginal microbiome test in 2021, Evvy its expanding its services. After taking a test, consumers can received personalized treatment, which may include prescriptions and one-on-one health coaching.

Model building is now simplified more than ever because of automation and tool intelligence achieved in model building. With a surplus of MLOps tools, users of all sizes and backgrounds are now focusing on model manufacturing. But the question remains - are all models usable?